Acute nasopharyngitis. Coryza (acute)Nasal catarrh, acute Nasopharyngitis
Conditions
Interventions
Intervention 1: intravenous lidocaine (1.5 mg/kg). Intervention 2: intravenous normal saline. Intervention 3: Topical lidocaine (2% lidocaine) on laryngeal mask airway. Intervention 4: Topical lubrica
Prevention
Placebo
Topical lidocaine (2% lidocaine) on laryngeal mask airway
Topical lubrication gel on laryngeal mask airway
intravenous lidocaine (1.5 mg/kg)
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All pediatric patients between 1-6 y-old whose parents mentioned mild URI symptoms (nasal discharge or congestion, cough, sneeze) started within last two weeks No evidence of bacterial infection (axillary temperature more than 38, ill appearance evaluated by anesthesiologist in charge, purulent discharge or sputum) No evidence of lower respiratory infection (crackle or wheeze) No evidence of medical condition (respiratory, cardiac or neurologic) Patients candidate for anesthesia to receive full ophthalmologic examination. These procedures were necessary to perform and further delay would have deleterious consequences. Exclusion criteria: Those with a probable difficult airway Hypersensitivity to drugs Patients who received hydrocortisone, dexamethasone or extra atropine and vasopressor Those who required muscle relaxant due to unpredicted surgery plan change or procedures lasting more than an hour
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough. Timepoint: Induction, maintenance, emergence, recovery. Method of measurement: observation and questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Desaturation (SPO2 less than 90% for more than one minute). Timepoint: induction, maintenace, emergence and recovery (continuous). Method of measurement: pulsoximetry.;Apnea (no airflow for more than 10 seconds). Timepoint: induction, maintenace, emergence and recovery. Method of measurement: Observation.;Laryngospasm (inspiratory stridor). Timepoint: induction, maintenance, emergence and recovery (every 5 minutes). Method of measurement: observation and questionnaire.;Bronchospasm (inspiratory or expiratory wheeze). Timepoint: induction, maintenance, emergence and recovery (every 5 minutes). Method of measurement: observation and questionnaire.;Vomiting. Timepoint: induction, maintenance, emergence and recovery (every 5 minutes). Method of measurement: observation and questionnaire.;Cardiac event (any medication for cardiac support). Timepoint: induction, maintenance, emergence and recovery. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Gharaei
Shahid Beheshti University of Medical Sciences
Outcome results
None listed